Global Topical Hemostatic Agents Market Research Report 2021-2027

  • receipt Report ID : 216121
  • calendar_today Published On: May, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare

The Topical Hemostatic Agents market report offers in-dept analysis on the global market size, market share, market growth, sales analysis, regional analysis, market developments, opportunities, and forecasts that will help you in strategizing and expanding your business.

As per the most recent analysis conducted by our research team, the global Topical Hemostatic Agents market size is projected to reach US$ XX million by 2027 from US $ XX million in 2020 at a CAGR of XX% during 2021-2027.

The report included detailed analysis on the Topical Hemostatic Agents production capacity, its market share by manufacturers, growth rate, regional production capacity, ex-factory rate, and other important data points. The report also covers Topical Hemostatic Agents consumption globally as well as thorough bifurcation into regional and country wise consumption.

The research team goes an additional mile to comprehensively cover other important aspects on Topical Hemostatic Agents market such as the market dynamics, market segmentation, competition, growth prospects, and growth strategies. The buyers of this report will have access to exclusive data that covers market share by applications, manufacturers, regions, and countries. The document also covers market size by type, market competition by manufacturers, sales volume, growth rate, revenue, price and gross margins. Moreover, the authors of this report provide authentic calculations and estimations for global revenue and volume by type segments for Topical Hemostatic Agents market covering the period 2016-2027.

This report includes the following key manufacturers. We can also add other companies of your choice and customize the report as per your requirements.

  • Ethicon
  • Pfizer
  • Baxter International
  • C. R. Bard
  • The Medicines Company
  • Anika Therapeutics
  • Advanced Medical Solutions
  • Integra LifeSciences
  • B Braun Melsungen
  • Gelita Medical
  • Equimedical
  • Vascular Solutions
  • Marine Polymer Technologies

Market Segment by Type

  • Gelation Sponge
  • Oxidized Regenerated Cellulose Based Hemostats
  • Others

Market Segment by Application

  • Hospitals
  • Surgical Centers
  • Nursing Homes

Market Segment by Regions and Countries

  • North America (United States, Canada, Mexico)
  • Asia-Pacific (China, India, Japan, Taiwan, South Korea, Australia, Indonesia, Singapore, Malaysia, Rest of Asia-Pacific)
  • Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
  • Central & South America (Brazil, Argentina, Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Turkey, Rest of Middle East & Africa)

The study objectives of this report are:

  • Overview of the Topical Hemostatic Agents market
  • Analysis on key market segments
  • Key manufacturer analysis based on production, sales, and revenue
  • Topical Hemostatic Agents market regional and country wise analysis for production and consumption
  • Study the forecast of market in respect to manufacturers, segments, and regions
  • Identify significant trends and factors driving the market growth
  • Analyse the available opportunities in the market by tracing high growth segments
  • Analyse competitive developments like acquisitions, expansions, product launches, agreements, etc.
  • Study the growth strategies of key manufacturers
  • SWOT analysis

In this study, the years considered to estimate the market size of Topical Hemostatic Agents are as follows:

History Year: 2016-2020

Base Year: 2020

Estimated Year: 2021

Forecast Year 2021 to 2027

Available Customizations

Market Research Place offers customizations according to the client's specific needs. The report can be customized on the basis of manufacturers, regions, applications, etc. Contact us to know more about the customization options.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Report Overview

1.1 Research Scope

1.2 Market Segment by Type

1.2.1 Global Topical Hemostatic Agents Market Size Growth Rate by Type

1.2.2 Gelation Sponge

1.2.3 Oxidized Regenerated Cellulose Based Hemostats

1.2.4 Others

1.3 Market Segment by Application

1.3.1 Global Topical Hemostatic Agents Market Share by Application (2016 VS 2021 VS 2027)

1.3.2 Hospitals

1.3.3 Surgical Centers

1.3.4 Nursing Homes

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global Topical Hemostatic Agents Market Size (2016-2027)

2.1.1 Global Topical Hemostatic Agents Revenue (2016-2027)

2.1.2 Global Topical Hemostatic Agents Sales (2016-2027)

2.2 Global Topical Hemostatic Agents Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027

2.2.1 Global Topical Hemostatic Agents Sales by Regions (2016-2021)

2.2.2 Global Topical Hemostatic Agents Revenue by Regions (2016-2021)

2.3 Global Topical Hemostatic Agents Market Size Forecast by Region

2.3.1 Global Topical Hemostatic Agents Sales Forecast by Region (2022-2027)

2.3.2 Global Topical Hemostatic Agents Revenue Forecast by Region (2022-2027)

2.4 Global Top Topical Hemostatic Agents Regions (Countries) Ranking by Market Size

2.5 Topical Hemostatic Agents Industry Trends

2.5.1 Topical Hemostatic Agents Market Trends

2.5.2 Topical Hemostatic Agents Market Drivers

2.5.3 Topical Hemostatic Agents Market Challenges

2.5.4 Topical Hemostatic Agents Market Restraints

3 Competitive Landscape by Manufacturers

3.1 Global Top Topical Hemostatic Agents Manufacturers by Sales (2016-2021)

3.1.1 Global Topical Hemostatic Agents Sales by Manufacturers (2016-2021)

3.1.2 Global Topical Hemostatic Agents Sales Market Share by Manufacturers (2016-2021)

3.1.3 Global 5 and 10 Largest Manufacturers by Topical Hemostatic Agents Sales in 2020

3.2 Global Top Manufacturers Topical Hemostatic Agents by Revenue

3.2.1 Global Topical Hemostatic Agents Revenue by Manufacturers (2016-2021)

3.2.2 Top Topical Hemostatic Agents Manufacturers Covered: Ranking by Revenue

3.2.3 Global Topical Hemostatic Agents Revenue Share by Manufacturers (2016-2021)

3.2.4 Global Topical Hemostatic Agents Market Concentration Ratio (CR5 and HHI)

3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Topical Hemostatic Agents as of 2020)

3.4 Global Topical Hemostatic Agents Average Selling Price (ASP) by Manufacturers

3.5 Key Manufacturers Topical Hemostatic Agents Plants/Factories Distribution and Area Served

3.6 Date of Key Manufacturers Enter into Topical Hemostatic Agents Market

3.7 Key Manufacturers Topical Hemostatic Agents Product Offered

3.8 Mergers & Acquisitions, Expansion Plans

4 Global Topical Hemostatic Agents Market Size by Type

4.1 Global Topical Hemostatic Agents Historic Market Review by Type (2016-2021)

4.1.1 Global Topical Hemostatic Agents Sales Market Share by Type (2016-2021)

4.1.2 Global Topical Hemostatic Agents Revenue Market Share by Type (2016-2021)

4.1.3 Topical Hemostatic Agents Price by Type (2016-2021)

4.2 Global Topical Hemostatic Agents Market Estimates and Forecasts by Type (2022-2027)

4.2.1 Global Topical Hemostatic Agents Sales Forecast by Type (2022-2027)

4.2.2 Global Topical Hemostatic Agents Revenue Forecast by Type (2022-2027)

4.2.3 Topical Hemostatic Agents Price Forecast by Type (2022-2027)

5 Global Topical Hemostatic Agents Market Size by Application

5.1 Global Topical Hemostatic Agents Historic Market Review by Application (2016-2021)

5.1.1 Global Topical Hemostatic Agents Sales Market Share by Application (2016-2021)

5.1.2 Global Topical Hemostatic Agents Revenue Market Share by Application (2016-2021)

5.1.3 Topical Hemostatic Agents Price by Application (2016-2021)

5.2 Global Topical Hemostatic Agents Market Estimates and Forecasts by Application (2022-2027)

5.2.1 Global Topical Hemostatic Agents Sales Forecast by Application (2022-2027)

5.2.2 Global Topical Hemostatic Agents Revenue Forecast by Application (2022-2027)

5.2.3 Topical Hemostatic Agents Price Forecast by Application (2022-2027)

6 North America

6.1 North America Topical Hemostatic Agents Sales Breakdown by Company

6.1.1 North America Topical Hemostatic Agents Sales by Company (2016-2027)

6.1.2 North America Topical Hemostatic Agents Revenue by Company (2016-2027)

6.2 North America Topical Hemostatic Agents Market Size by Type (2016-2027)

6.2.1 North America Topical Hemostatic Agents Sales by Type (2016-2027)

6.2.2 North America Topical Hemostatic Agents Revenue by Type (2016-2027)

6.3 North America Topical Hemostatic Agents Market Size by Application (2016-2027)

6.3.1 North America Topical Hemostatic Agents Sales by Application (2016-2027)

6.3.2 North America Topical Hemostatic Agents Revenue by Application (2016-2027)

6.4 North America Topical Hemostatic Agents Market Size by Country

6.4.1 North America Topical Hemostatic Agents Sales by Country (2016-2027)

6.4.2 North America Topical Hemostatic Agents Revenue by Country (2016-2027)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Topical Hemostatic Agents Sales Breakdown by Company

7.1.1 Europe Topical Hemostatic Agents Sales by Company (2016-2027)

7.1.2 Europe Topical Hemostatic Agents Revenue by Company (2016-2027)

7.2 Europe Topical Hemostatic Agents Market Size by Type (2016-2027)

7.2.1 Europe Topical Hemostatic Agents Sales by Type (2016-2027)

7.2.2 Europe Topical Hemostatic Agents Revenue by Type (2016-2027)

7.3 Europe Topical Hemostatic Agents Market Size by Application (2016-2027)

7.3.1 Europe Topical Hemostatic Agents Sales by Application (2016-2027)

7.3.2 Europe Topical Hemostatic Agents Revenue by Application (2016-2027)

7.4 Europe Topical Hemostatic Agents Market Size by Country

7.4.1 Europe Topical Hemostatic Agents Sales by Country (2016-2027)

7.4.2 Europe Topical Hemostatic Agents Revenue by Country (2016-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

8 Asia Pacific

8.1 Asia Pacific Topical Hemostatic Agents Sales Breakdown by Company

8.1.1 Asia Pacific Topical Hemostatic Agents Sales by Company (2016-2027)

8.1.2 Asia Pacific Topical Hemostatic Agents Revenue by Company (2016-2027)

8.2 Asia Pacific Topical Hemostatic Agents Market Size by Type (2016-2027)

8.2.1 Asia Pacific Topical Hemostatic Agents Sales by Type (2016-2027)

8.2.2 Asia Pacific Topical Hemostatic Agents Revenue by Type (2016-2027)

8.3 Asia Pacific Topical Hemostatic Agents Market Size by Application (2016-2027)

8.3.1 Asia Pacific Topical Hemostatic Agents Sales by Application (2016-2027)

8.3.2 Asia Pacific Topical Hemostatic Agents Revenue by Application (2016-2027)

8.4 Asia Pacific Topical Hemostatic Agents Market Size by Regions

8.4.1 Asia Pacific Topical Hemostatic Agents Sales by Regions

8.4.2 Asia Pacific Topical Hemostatic Agents Revenue by Regions

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 India

8.4.7 Australia

8.4.8 Taiwan

8.4.9 Indonesia

8.4.10 Thailand

8.4.11 Malaysia

8.4.12 Philippines

8.4.13 Vietnam

9 Latin America

9.1 Latin America Topical Hemostatic Agents Sales Breakdown by Company

9.1.1 Latin America Topical Hemostatic Agents Sales by Company (2016-2027)

9.1.2 Latin America Topical Hemostatic Agents Revenue by Company (2016-2027)

9.2 Latin America Topical Hemostatic Agents Market Size by Type (2016-2027)

9.2.1 Latin America Topical Hemostatic Agents Sales by Type (2016-2027)

9.2.2 Latin America Topical Hemostatic Agents Revenue by Type (2016-2027)

9.3 Latin America Topical Hemostatic Agents Market Size by Application (2016-2027)

9.3.1 Latin America Topical Hemostatic Agents Sales by Application (2016-2027)

9.3.2 Latin America Topical Hemostatic Agents Revenue by Application (2016-2027)

9.4 Latin America Topical Hemostatic Agents Market Size by Country

9.4.1 Latin America Topical Hemostatic Agents Sales by Country (2016-2027)

9.4.2 Latin America Topical Hemostatic Agents Revenue by Country (2016-2027)

9.4.3 Mexico

9.4.4 Brazil

9.4.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Topical Hemostatic Agents Sales Breakdown by Company

10.1.1 Middle East and Africa Topical Hemostatic Agents Sales by Company (2016-2027)

10.1.2 Middle East and Africa Topical Hemostatic Agents Revenue by Company (2016-2027)

10.2 Middle East and Africa Topical Hemostatic Agents Market Size by Type (2016-2027)

10.2.1 Middle East and Africa Topical Hemostatic Agents Sales by Type (2016-2027)

10.2.2 Middle East and Africa Topical Hemostatic Agents Revenue by Type (2016-2027)

10.3 Middle East and Africa Topical Hemostatic Agents Market Size by Application (2016-2027)

10.3.1 Middle East and Africa Topical Hemostatic Agents Sales by Application (2016-2027)

10.3.2 Middle East and Africa Topical Hemostatic Agents Revenue by Application (2016-2027)

10.4 Middle East and Africa Topical Hemostatic Agents Market Size by Country

10.4.1 Middle East and Africa Topical Hemostatic Agents Sales by Country (2016-2027)

10.4.2 Middle East and Africa Topical Hemostatic Agents Revenue by Country (2016-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 U.A.E

11 Company Profiles

11.1 Ethicon

11.1.1 Ethicon Corporation Information

11.1.2 Ethicon Overview

11.1.3 Ethicon Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.1.4 Ethicon Topical Hemostatic Agents Products and Services

11.1.5 Ethicon Topical Hemostatic Agents SWOT Analysis

11.1.6 Ethicon Recent Developments

11.2 Pfizer

11.2.1 Pfizer Corporation Information

11.2.2 Pfizer Overview

11.2.3 Pfizer Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.2.4 Pfizer Topical Hemostatic Agents Products and Services

11.2.5 Pfizer Topical Hemostatic Agents SWOT Analysis

11.2.6 Pfizer Recent Developments

11.3 Baxter International

11.3.1 Baxter International Corporation Information

11.3.2 Baxter International Overview

11.3.3 Baxter International Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.3.4 Baxter International Topical Hemostatic Agents Products and Services

11.3.5 Baxter International Topical Hemostatic Agents SWOT Analysis

11.3.6 Baxter International Recent Developments

11.4 C. R. Bard

11.4.1 C. R. Bard Corporation Information

11.4.2 C. R. Bard Overview

11.4.3 C. R. Bard Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.4.4 C. R. Bard Topical Hemostatic Agents Products and Services

11.4.5 C. R. Bard Topical Hemostatic Agents SWOT Analysis

11.4.6 C. R. Bard Recent Developments

11.5 The Medicines Company

11.5.1 The Medicines Company Corporation Information

11.5.2 The Medicines Company Overview

11.5.3 The Medicines Company Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.5.4 The Medicines Company Topical Hemostatic Agents Products and Services

11.5.5 The Medicines Company Topical Hemostatic Agents SWOT Analysis

11.5.6 The Medicines Company Recent Developments

11.6 Anika Therapeutics

11.6.1 Anika Therapeutics Corporation Information

11.6.2 Anika Therapeutics Overview

11.6.3 Anika Therapeutics Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.6.4 Anika Therapeutics Topical Hemostatic Agents Products and Services

11.6.5 Anika Therapeutics Topical Hemostatic Agents SWOT Analysis

11.6.6 Anika Therapeutics Recent Developments

11.7 Advanced Medical Solutions

11.7.1 Advanced Medical Solutions Corporation Information

11.7.2 Advanced Medical Solutions Overview

11.7.3 Advanced Medical Solutions Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.7.4 Advanced Medical Solutions Topical Hemostatic Agents Products and Services

11.7.5 Advanced Medical Solutions Topical Hemostatic Agents SWOT Analysis

11.7.6 Advanced Medical Solutions Recent Developments

11.8 Integra LifeSciences

11.8.1 Integra LifeSciences Corporation Information

11.8.2 Integra LifeSciences Overview

11.8.3 Integra LifeSciences Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.8.4 Integra LifeSciences Topical Hemostatic Agents Products and Services

11.8.5 Integra LifeSciences Topical Hemostatic Agents SWOT Analysis

11.8.6 Integra LifeSciences Recent Developments

11.9 B Braun Melsungen

11.9.1 B Braun Melsungen Corporation Information

11.9.2 B Braun Melsungen Overview

11.9.3 B Braun Melsungen Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.9.4 B Braun Melsungen Topical Hemostatic Agents Products and Services

11.9.5 B Braun Melsungen Topical Hemostatic Agents SWOT Analysis

11.9.6 B Braun Melsungen Recent Developments

11.10 Gelita Medical

11.10.1 Gelita Medical Corporation Information

11.10.2 Gelita Medical Overview

11.10.3 Gelita Medical Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.10.4 Gelita Medical Topical Hemostatic Agents Products and Services

11.10.5 Gelita Medical Topical Hemostatic Agents SWOT Analysis

11.10.6 Gelita Medical Recent Developments

11.11 Equimedical

11.11.1 Equimedical Corporation Information

11.11.2 Equimedical Overview

11.11.3 Equimedical Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.11.4 Equimedical Topical Hemostatic Agents Products and Services

11.11.5 Equimedical Recent Developments

11.12 Vascular Solutions

11.12.1 Vascular Solutions Corporation Information

11.12.2 Vascular Solutions Overview

11.12.3 Vascular Solutions Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.12.4 Vascular Solutions Topical Hemostatic Agents Products and Services

11.12.5 Vascular Solutions Recent Developments

11.13 Marine Polymer Technologies

11.13.1 Marine Polymer Technologies Corporation Information

11.13.2 Marine Polymer Technologies Overview

11.13.3 Marine Polymer Technologies Topical Hemostatic Agents Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.13.4 Marine Polymer Technologies Topical Hemostatic Agents Products and Services

11.13.5 Marine Polymer Technologies Recent Developments

12 Value Chain and Sales Channels Analysis

12.1 Topical Hemostatic Agents Value Chain Analysis

12.2 Topical Hemostatic Agents Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Topical Hemostatic Agents Production Mode & Process

12.4 Topical Hemostatic Agents Sales and Marketing

12.4.1 Topical Hemostatic Agents Sales Channels

12.4.2 Topical Hemostatic Agents Distributors

12.5 Topical Hemostatic Agents Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

List of Tables

Table 1. Global Topical Hemostatic Agents Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)

Table 2. Major Manufacturers of Gelation Sponge

Table 3. Major Manufacturers of Oxidized Regenerated Cellulose Based Hemostats

Table 4. Major Manufacturers of Others

Table 5. Global Topical Hemostatic Agents Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)

Table 6. Global Market Topical Hemostatic Agents Market Size (US$ Million) by Region: 2016 VS 2021 VS 2027

Table 7. Global Topical Hemostatic Agents Sales by Region (2016-2021) & (K Units)

Table 8. Global Topical Hemostatic Agents Sales Market Share by Region (2016-2021)

Table 9. Global Topical Hemostatic Agents Revenue by Region (2016-2021) & (US$ Million)

Table 10. Global Topical Hemostatic Agents Revenue Market Share by Region (2016-2021)

Table 11. Global Topical Hemostatic Agents Sales Forecast by Region (2022-2027) & (K Units)

Table 12. Global Topical Hemostatic Agents Sales Market Share Forecast by Region (2022-2027)

Table 13. Global Topical Hemostatic Agents Revenue Forecast by Region (2022-2027) & (US$ Million)

Table 14. Global Topical Hemostatic Agents Revenue Market Share Forecast by Region (2022-2027)

Table 15. Top Topical Hemostatic Agents Regions (Countries) Ranking by Market Size (US$ Million) in 2020

Table 16. Topical Hemostatic Agents Market Trends

Table 17. Topical Hemostatic Agents Market Drivers

Table 18. Topical Hemostatic Agents Market Challenges

Table 19. Topical Hemostatic Agents Market Restraints

Table 20. Global Topical Hemostatic Agents Sales by Manufacturers (2016-2021) & (K Units)

Table 21. Global Topical Hemostatic Agents Sales Share by Manufacturers (2016-2021)

Table 22. Global Topical Hemostatic Agents Revenue by Manufacturers (2016-2021) & (US$ Million)

Table 23. Ranking of Global Top Topical Hemostatic Agents Manufacturers by Revenue (US$ Million) in 2020

Table 24. Topical Hemostatic Agents Revenue Share by Manufacturers (2016-2021)

Table 25. Global Topical Hemostatic Agents Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Topical Hemostatic Agents as of 2020)

Table 27. Key Manufacturers Topical Hemostatic Agents Average Selling Price (ASP) & (2016-2021) & (USD/Unit)

Table 28. Key Manufacturers Topical Hemostatic Agents Plants/Factories Distribution

Table 29. Key Manufacturers Topical Hemostatic Agents Area Served

Table 30. Date of Key Manufacturers Enter into Topical Hemostatic Agents Market

Table 31. Key Manufacturers Topical Hemostatic Agents Product Type

Table 32. Mergers & Acquisitions, Expansion Plans

Table 33. Global Topical Hemostatic Agents Sales (K Units) by Type (2016-2021)

Table 34. Global Topical Hemostatic Agents Sales Share by Type (2016-2021)

Table 35. Global Topical Hemostatic Agents Revenue (US$ Million) Market Share by Type (2016-2021)

Table 36. Global Topical Hemostatic Agents Price (K Units) by Type (2016-2021)

Table 37. Global Topical Hemostatic Agents Sales (K Units) by Type (2022-2027)

Table 38. Global Topical Hemostatic Agents Sales Share by Type (2022-2027)

Table 39. Global Topical Hemostatic Agents Revenue (US$ Million) Market Share by Type (2022-2027)

Table 40. Global Topical Hemostatic Agents Revenue Share by Type (2022-2027)

Table 41. Global Topical Hemostatic Agents Price (K Units) by Type (2022-2027)

Table 42. Global Topical Hemostatic Agents Sales (K Units) by Application (2016-2021)

Table 43. Global Topical Hemostatic Agents Sales Share by Application (2016-2021)

Table 44. Global Topical Hemostatic Agents Revenue (US$ Million) Market Share by Application (2016-2021)

Table 45. Global Topical Hemostatic Agents Price (K Units) by Application (2016-2021)

Table 46. Global Topical Hemostatic Agents Sales (K Units) by Application (2022-2027)

Table 47. Global Topical Hemostatic Agents Sales Share by Application (2022-2027)

Table 48. Global Topical Hemostatic Agents Revenue (US$ Million) Market Share by Application (2022-2027)

Table 49. Global Topical Hemostatic Agents Revenue Share by Application (2022-2027)

Table 50. Global Topical Hemostatic Agents Price (K Units) by Application (2022-2027)

Table 51. North America Topical Hemostatic Agents Sales by Company (2016-2021) & (K Units)

Table 52. North America Topical Hemostatic Agents Sales Market Share by Company (2016-2021)

Table 53. North America Topical Hemostatic Agents Revenue by Company (2016-2021) & (US$ Million)

Table 54. North America Topical Hemostatic Agents Revenue Market Share by Company (2016-2021)

Table 55. North America Topical Hemostatic Agents Sales by Application (2016-2021) & (K Units)

Table 56. North America Topical Hemostatic Agents Sales by Application (2022-2027) & (K Units)

Table 57. North America Topical Hemostatic Agents Revenue by Application (2016-2021) & (US$ Million)

Table 58. North America Topical Hemostatic Agents Revenue by Application (2022-2027) & (US$ Million)

Table 59. North America Topical Hemostatic Agents Sales by Application (2016-2021) & (K Units)

Table 60. North America Topical Hemostatic Agents Sales by Application (2022-2027) & (K Units)

Table 61. North America Topical Hemostatic Agents Revenue by Application (2016-2021) & (US$ Million)

Table 62. North America Topical Hemostatic Agents Revenue by Application (2022-2027) & (US$ Million)

Table 63. North America Topical Hemostatic Agents Sales by Country (2016-2021) & (K Units)

Table 64. North America Topical Hemostatic Agents Sales by Country (2022-2027) & (K Units)

Table 65. North America Topical Hemostatic Agents Revenue by Country (2016-2021) & (US$ Million)

Table 66. North America Topical Hemostatic Agents Revenue by Country (2022-2027) & (US$ Million)

Table 67. Europe Topical Hemostatic Agents Sales by Company (2016-2021) & (K Units)

Table 68. Europe Topical Hemostatic Agents Sales Market Share by Company (2016-2021)

Table 69. Europe Topical Hemostatic Agents Revenue by Company (2016-2021) & (US$ Million)

Table 70. Europe Topical Hemostatic Agents Revenue Market Share by Company (2016-2021)

Table 71. Europe Topical Hemostatic Agents Sales by Application (2016-2021) & (K Units)

Table 72. Europe Topical Hemostatic Agents Sales by Application (2022-2027) & (K Units)

Table 73. Europe Topical Hemostatic Agents Revenue by Application (2016-2021) & (US$ Million)

Table 74. Europe Topical Hemostatic Agents Revenue by Application (2022-2027) & (US$ Million)

Table 75. Europe Topical Hemostatic Agents Sales by Application (2016-2021) & (K Units)

Table 76. Europe Topical Hemostatic Agents Sales by Application (2022-2027) & (K Units)

Table 77. Europe Topical Hemostatic Agents Revenue by Application (2016-2021) & (US$ Million)

Table 78. Europe Topical Hemostatic Agents Revenue by Application (2022-2027) & (US$ Million)

Table 79. Europe Topical Hemostatic Agents Sales by Country (2016-2021) & (K Units)

Table 80. Europe Topical Hemostatic Agents Sales by Country (2022-2027) & (K Units)

Table 81. Europe Topical Hemostatic Agents Revenue by Country (2016-2021) & (US$ Million)

Table 82. Europe Topical Hemostatic Agents Revenue by Country (2022-2027) & (US$ Million)

Table 83. Asia Pacific Topical Hemostatic Agents Sales by Company (2016-2021) & (K Units)

Table 84. Asia Pacific Topical Hemostatic Agents Sales Market Share by Company (2016-2021)

Table 85. Asia Pacific Topical Hemostatic Agents Revenue by Company (2016-2021) & (US$ Million)

Table 86. Asia Pacific Topical Hemostatic Agents Revenue Market Share by Company (2016-2021)

Table 87. Asia Pacific Topical Hemostatic Agents Sales by Application (2016-2021) & (K Units)

Table 88. Asia Pacific Topical Hemostatic Agents Sales by Application (2022-2027) & (K Units)

Table 89. Asia Pacific Topical Hemostatic Agents Revenue by Application (2016-2021) & (US$ Million)

Table 90. Asia Pacific Topical Hemostatic Agents Revenue by Application (2022-2027) & (US$ Million)

Table 91. Asia Pacific Topical Hemostatic Agents Sales by Application (2016-2021) & (K Units)

Table 92. Asia Pacific Topical Hemostatic Agents Sales by Application (2022-2027) & (K Units)

Table 93. Asia Pacific Topical Hemostatic Agents Revenue by Application (2016-2021) & (US$ Million)

Table 94. Asia Pacific Topical Hemostatic Agents Revenue by Application (2022-2027) & (US$ Million)

Table 95. Asia Pacific Topical Hemostatic Agents Sales by Region (2016-2021) & (K Units)

Table 96. Asia Pacific Topical Hemostatic Agents Sales by Region (2022-2027) & (K Units)

Table 97. Asia Pacific Topical Hemostatic Agents Revenue by Region (2016-2021) & (US$ Million)

Table 98. Asia Pacific Topical Hemostatic Agents Revenue by Region (2022-2027) & (US$ Million)

Table 99. Latin America Topical Hemostatic Agents Sales by Company (2016-2021) & (K Units)

Table 100. Latin America Topical Hemostatic Agents Sales Market Share by Company (2016-2021)

Table 101. Latin America Topical Hemostatic Agents Revenue by Company (2016-2021) & (US$ Million)

Table 102. Latin America Topical Hemostatic Agents Revenue Market Share by Company (2016-2021)

Table 103. Latin America Topical Hemostatic Agents Sales by Application (2016-2021) & (K Units)

Table 104. Latin America Topical Hemostatic Agents Sales by Application (2022-2027) & (K Units)

Table 105. Latin America Topical Hemostatic Agents Revenue by Application (2016-2021) & (US$ Million)

Table 106. Latin America Topical Hemostatic Agents Revenue by Application (2022-2027) & (US$ Million)

Table 107. Latin America Topical Hemostatic Agents Sales by Application (2016-2021) & (K Units)

Table 108. Latin America Topical Hemostatic Agents Sales by Application (2022-2027) & (K Units)

Table 109. Latin America Topical Hemostatic Agents Revenue by Application (2016-2021) & (US$ Million)

Table 110. Latin America Topical Hemostatic Agents Revenue by Application (2022-2027) & (US$ Million)

Table 111. Latin America Topical Hemostatic Agents Sales by Country (2016-2021) & (K Units)

Table 112. Latin America Topical Hemostatic Agents Sales by Country (2022-2027) & (K Units)

Table 113. Latin America Topical Hemostatic Agents Revenue by Country (2016-2021) & (US$ Million)

Table 114. Latin America Topical Hemostatic Agents Revenue by Country (2022-2027) & (US$ Million)

Table 115. Middle East and Africa Topical Hemostatic Agents Sales by Company (2016-2021) & (K Units)

Table 116. Middle East and Africa Topical Hemostatic Agents Sales Market Share by Company (2016-2021)

Table 117. Middle East and Africa Topical Hemostatic Agents Revenue by Company (2016-2021) & (US$ Million)

Table 118. Middle East and Africa Topical Hemostatic Agents Revenue Market Share by Company (2016-2021)

Table 119. Middle East and Africa Topical Hemostatic Agents Sales by Application (2016-2021) & (K Units)

Table 120. Middle East and Africa Topical Hemostatic Agents Sales by Application (2022-2027) & (K Units)

Table 121. Middle East and Africa Topical Hemostatic Agents Revenue by Application (2016-2021) & (US$ Million)

Table 122. Middle East and Africa Topical Hemostatic Agents Revenue by Application (2022-2027) & (US$ Million)

Table 123. Middle East and Africa Topical Hemostatic Agents Sales by Application (2016-2021) & (K Units)

Table 124. Middle East and Africa Topical Hemostatic Agents Sales by Application (2022-2027) & (K Units)

Table 125. Middle East and Africa Topical Hemostatic Agents Revenue by Application (2016-2021) & (US$ Million)

Table 126. Middle East and Africa Topical Hemostatic Agents Revenue by Application (2022-2027) & (US$ Million)

Table 127. Middle East and Africa Topical Hemostatic Agents Sales by Country (2016-2021) & (K Units)

Table 128. Middle East and Africa Topical Hemostatic Agents Sales by Country (2022-2027) & (K Units)

Table 129. Middle East and Africa Topical Hemostatic Agents Revenue by Country (2016-2021) & (US$ Million)

Table 130. Middle East and Africa Topical Hemostatic Agents Revenue by Country (2022-2027) & (US$ Million)

Table 131. Ethicon Corporation Information

Table 132. Ethicon Description and Overview

Table 133. Ethicon Topical Hemostatic Agents Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 134. Ethicon Topical Hemostatic Agents Product and Services

Table 135. Ethicon Topical Hemostatic Agents SWOT Analysis

Table 136. Ethicon Recent Developments

Table 137. Pfizer Corporation Information

Table 138. Pfizer Description and Overview

Table 139. Pfizer Topical Hemostatic Agents Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 140. Pfizer Topical Hemostatic Agents Product and Services

Table 141. Pfizer Topical Hemostatic Agents SWOT Analysis

Table 142. Pfizer Recent Developments

Table 143. Baxter International Corporation Information

Table 144. Baxter International Description and Overview

Table 145. Baxter International Topical Hemostatic Agents Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 146. Baxter International Topical Hemostatic Agents Product and Services

Table 147. Baxter International Topical Hemostatic Agents SWOT Analysis

Table 148. Baxter International Recent Developments

Table 149. C. R. Bard Corporation Information

Table 150. C. R. Bard Description and Overview

Table 151. C. R. Bard Topical Hemostatic Agents Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 152. C. R. Bard Topical Hemostatic Agents Product and Services

Table 153. C. R. Bard Topical Hemostatic Agents SWOT Analysis

Table 154. C. R. Bard Recent Developments

Table 155. The Medicines Company Corporation Information

Table 156. The Medicines Company Description and Overview

Table 157. The Medicines Company Topical Hemostatic Agents Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 158. The Medicines Company Topical Hemostatic Agents Product and Services

Table 159. The Medicines Company Topical Hemostatic Agents SWOT Analysis

Table 160. The Medicines Company Recent Developments

Table 161. Anika Therapeutics Corporation Information

Table 162. Anika Therapeutics Description and Overview

Table 163. Anika Therapeutics Topical Hemostatic Agents Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 164. Anika Therapeutics Topical Hemostatic Agents Product and Services

Table 165. Anika Therapeutics Topical Hemostatic Agents SWOT Analysis

Table 166. Anika Therapeutics Recent Developments

Table 167. Advanced Medical Solutions Corporation Information

Table 168. Advanced Medical Solutions Description and Overview

Table 169. Advanced Medical Solutions Topical Hemostatic Agents Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 170. Advanced Medical Solutions Topical Hemostatic Agents Product and Services

Table 171. Advanced Medical Solutions Topical Hemostatic Agents SWOT Analysis

Table 172. Advanced Medical Solutions Recent Developments

Table 173. Integra LifeSciences Corporation Information

Table 174. Integra LifeSciences Description and Overview

Table 175. Integra LifeSciences Topical Hemostatic Agents Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 176. Integra LifeSciences Topical Hemostatic Agents Product and Services

Table 177. Integra LifeSciences Topical Hemostatic Agents SWOT Analysis

Table 178. Integra LifeSciences Recent Developments

Table 179. B Braun Melsungen Corporation Information

Table 180. B Braun Melsungen Description and Overview

Table 181. B Braun Melsungen Topical Hemostatic Agents Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 182. B Braun Melsungen Topical Hemostatic Agents Product and Services

Table 183. B Braun Melsungen Topical Hemostatic Agents SWOT Analysis

Table 184. B Braun Melsungen Recent Developments

Table 185. Gelita Medical Corporation Information

Table 186. Gelita Medical Description and Overview

Table 187. Gelita Medical Topical Hemostatic Agents Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 188. Gelita Medical Topical Hemostatic Agents Product and Services

Table 189. Gelita Medical Topical Hemostatic Agents SWOT Analysis

Table 190. Gelita Medical Recent Developments

Table 191. Equimedical Corporation Information

Table 192. Equimedical Description and Overview

Table 193. Equimedical Topical Hemostatic Agents Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 194. Equimedical Topical Hemostatic Agents Product and Services

Table 195. Equimedical Recent Developments

Table 196. Vascular Solutions Corporation Information

Table 197. Vascular Solutions Description and Overview

Table 198. Vascular Solutions Topical Hemostatic Agents Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 199. Vascular Solutions Topical Hemostatic Agents Product and Services

Table 200. Vascular Solutions Recent Developments

Table 201. Marine Polymer Technologies Corporation Information

Table 202. Marine Polymer Technologies Description and Overview

Table 203. Marine Polymer Technologies Topical Hemostatic Agents Sales (K Units), Revenue (Million US$), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2016-2021)

Table 204. Marine Polymer Technologies Topical Hemostatic Agents Product and Services

Table 205. Marine Polymer Technologies Recent Developments

Table 206. Key Raw Materials Lists

Table 207. Raw Materials Key Suppliers Lists

Table 208. Topical Hemostatic Agents Distributors List

Table 209. Topical Hemostatic Agents Customers List

Table 210. Research Programs/Design for This Report

Table 211. Key Data Information from Secondary Sources

Table 212. Key Data Information from Primary Sources

List of Figures

Figure 1. Topical Hemostatic Agents Product Picture

Figure 2. Global Topical Hemostatic Agents Sales Market Share by Type in 2020 & 2027

Figure 3. Gelation Sponge Picture

Figure 4. Oxidized Regenerated Cellulose Based Hemostats Picture

Figure 5. Others Picture

Figure 6. Global Topical Hemostatic Agents Sales Market Share by Application in 2020 & 2027

Figure 7. Hospitals Use Case

Figure 8. Surgical Centers Use Case

Figure 9. Nursing Homes Use Case

Figure 10. Topical Hemostatic Agents Report Years Considered

Figure 11. Global Topical Hemostatic Agents Revenue, (US$ Million), 2016 VS 2021 VS 2027

Figure 12. Global Topical Hemostatic Agents Market Size 2016-2027 (US$ Million)

Figure 13. Global Topical Hemostatic Agents Sales (2016-2021) & (K Units)

Figure 14. Global Topical Hemostatic Agents Market Size Market Share by Region: 2020 VS 2027

Figure 15. Global Topical Hemostatic Agents Sales Market Share by Region (2016-2021)

Figure 16. Global Topical Hemostatic Agents Sales Market Share by Region in 2020

Figure 17. Global Topical Hemostatic Agents Revenue Market Share by Region in 2016 VS 2020

Figure 18. Global Topical Hemostatic Agents Sales Share by Manufacturers In 2020

Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Topical Hemostatic Agents Sales in 2020

Figure 20. Topical Hemostatic Agents Revenue Share by Manufacturers In 2020

Figure 21. Topical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020

Figure 22. Global Topical Hemostatic Agents Revenue Share by Type (2016-2021)

Figure 23. Global Topical Hemostatic Agents Revenue Growth Rate by Type in 2016 & 2020

Figure 24. Global Topical Hemostatic Agents Revenue Share by Application (2016-2021)

Figure 25. Global Topical Hemostatic Agents Revenue Growth Rate by Application in 2016 & 2020

Figure 26. North America Topical Hemostatic Agents Sales Market Share by Type (2016-2027)

Figure 27. North America Topical Hemostatic Agents Revenue Market Share by Type (2016-2027)

Figure 28. North America Topical Hemostatic Agents Sales Market Share by Application (2016-2027)

Figure 29. North America Topical Hemostatic Agents Revenue Market Share by Application (2016-2027)

Figure 30. North America Topical Hemostatic Agents Sales Share by Country (2016-2027)

Figure 31. North America Topical Hemostatic Agents Revenue Share by Country (2016-2027)

Figure 32. U.S. Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 33. Canada Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 34. Europe Topical Hemostatic Agents Sales Market Share by Type (2016-2027)

Figure 35. Europe Topical Hemostatic Agents Revenue Market Share by Type (2016-2027)

Figure 36. Europe Topical Hemostatic Agents Sales Market Share by Application (2016-2027)

Figure 37. Europe Topical Hemostatic Agents Revenue Market Share by Application (2016-2027)

Figure 38. Europe Topical Hemostatic Agents Sales Share by Country (2016-2027)

Figure 39. Europe Topical Hemostatic Agents Revenue Share by Country (2016-2027)

Figure 40. Germany Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 41. France Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 42. U.K. Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 43. Italy Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 44. Russia Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 45. Asia Pacific Topical Hemostatic Agents Sales Market Share by Type (2016-2027)

Figure 46. Asia Pacific Topical Hemostatic Agents Revenue Market Share by Type (2016-2027)

Figure 47. Asia Pacific Topical Hemostatic Agents Sales Market Share by Application (2016-2027)

Figure 48. Asia Pacific Topical Hemostatic Agents Revenue Market Share by Application (2016-2027)

Figure 49. Asia Pacific Topical Hemostatic Agents Sales Share by Region (2016-2027)

Figure 50. Asia Pacific Topical Hemostatic Agents Revenue Share by Region (2016-2027)

Figure 51. China Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 52. Japan Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 53. South Korea Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 54. India Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 55. Australia Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 56. Taiwan Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 57. Indonesia Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 58. Thailand Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 59. Malaysia Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 60. Philippines Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 61. Vietnam Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 62. Latin America Topical Hemostatic Agents Sales Market Share by Type (2016-2027)

Figure 63. Latin America Topical Hemostatic Agents Revenue Market Share by Type (2016-2027)

Figure 64. Latin America Topical Hemostatic Agents Sales Market Share by Application (2016-2027)

Figure 65. Latin America Topical Hemostatic Agents Revenue Market Share by Application (2016-2027)

Figure 66. Latin America Topical Hemostatic Agents Sales Share by Country (2016-2027)

Figure 67. Latin America Topical Hemostatic Agents Revenue Share by Country (2016-2027)

Figure 68. Mexico Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 69. Brazil Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 70. Argentina Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 71. Middle East and Africa Topical Hemostatic Agents Sales Market Share by Type (2016-2027)

Figure 72. Middle East and Africa Topical Hemostatic Agents Revenue Market Share by Type (2016-2027)

Figure 73. Middle East and Africa Topical Hemostatic Agents Sales Market Share by Application (2016-2027)

Figure 74. Middle East and Africa Topical Hemostatic Agents Revenue Market Share by Application (2016-2027)

Figure 75. Middle East and Africa Topical Hemostatic Agents Sales Share by Country (2016-2027)

Figure 76. Middle East and Africa Topical Hemostatic Agents Revenue Share by Country (2016-2027)

Figure 77. Turkey Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 78. Saudi Arabia Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 79. U.A.E Topical Hemostatic Agents Revenue (2016-2027) & (US$ Million)

Figure 80. Topical Hemostatic Agents Value Chain

Figure 81. Topical Hemostatic Agents Production Process

Figure 82. Channels of Distribution

Figure 83. Distributors Profiles

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

Please fill the form below, to recieve the report sample


+1